A study for a 74 year old man who takes Crescormon, Flecainide Acetate, Panwarfin - from FDA reports

34 males aged 74 (±5) who take the same drugs are studied. This is a personalized study for a 74 year old male patient who has A-Fib, Congenital Afibrinogenemia. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Oct, 04, 2018

34 males aged 74 (±5) who take Crescormon, Flecainide Acetate, Panwarfin are studied.

Number of reports submitted per year:

Crescormon, Flecainide Acetate, Panwarfin for a 74-year old man.

Information of the patient in this study:

  • Age: 74
  • Gender: male
  • Conditions: A-Fib, Congenital Afibrinogenemia
  • Drugs taken:
    • Flecanide (None)
    • Panwarfin (warfarin sodium)
    • Crescormon (somatropin)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. C-reactive protein increased
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Anaemia (lack of blood)
  4. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Hepatic enzyme abnormal
  6. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  7. Haematocrit decreased
  8. Nausea (feeling of having an urge to vomit)
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Pneumonia
  2. Loose stools
  3. Diabetes
  4. Injection site erythema (redness at injection site)
  5. Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
  6. Hypertension aggravated (high blood pressure-aggravated)
  7. Blood albumin decreased
  8. Haematoma (collection of blood outside the blood vessels)
  9. Breast cancer recurrent
  10. Hepatic enzyme abnormal

Top conditions involved for these people *:

  1. Non-Hodgkin's Lymphoma Unspecified Histology Indolent Stage Iv (malignant (cancer) cells form in the lymph system- unspecified histology indolent stage iv): 3 people, 8.82%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 8.82%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 8.82%
  4. Hepatitis B : 2 people, 5.88%
  5. Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 2 people, 5.88%
  6. Constipation : 2 people, 5.88%
  7. Dehydration (dryness resulting from the removal of water): 2 people, 5.88%
  8. Gastritis (inflammation of stomach): 2 people, 5.88%
  9. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 2.94%
  10. Bipolar Disorder (mood disorder): 1 person, 2.94%

Top co-used drugs for these people *:

  1. Lipitor (7 people, 20.59%)
  2. Zocor (6 people, 17.65%)
  3. Spiriva (5 people, 14.71%)
  4. Dexamethasone (5 people, 14.71%)
  5. Lanoxin (5 people, 14.71%)
  6. Tylenol (4 people, 11.76%)
  7. Lasix (4 people, 11.76%)
  8. Furosemide (4 people, 11.76%)
  9. Tikosyn (4 people, 11.76%)
  10. Metoprolol Tartrate (4 people, 11.76%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!